New Key Statistics Module, Z-Score and F-Score
NAS:CLGN Key Ratios
| Market Cap $ M | 68.15 |
| Enterprise Value $ M | 44.64 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 148.75 |
| Forward PE Ratio | 17.88 |
| Price/Book | 2.40 |
| Price/Sales | 6.38 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 10.00 |
| EPS (TTM) $ | -0.64 |
| Beneish M-Score | 27.05 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.94 |
| EV-to-EBITDA | -6.96 |
| PEG | -- |
| Shares Outstanding M | 11.45 |
| Net Margin (%) | -64.05 |
| Operating Margin % | -68.55 |
| Pre-tax Margin (%) | -64.05 |
| Quick Ratio | 8.40 |
| Current Ratio | 8.62 |
| ROA % (ttm) | -18.79 |
| ROE % (ttm) | -22.08 |
| ROIC % (ttm) | -79.00 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.63 |
CLGN Number of Guru Trades
CLGN Volume of Guru Trades
Gurus Latest Trades with NAS:CLGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLGN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CollPlant Biotechnologies Ltd Insider Transactions
No Available Data
News about NAS:CLGN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers